Cargando…

Molecular Markers of Tumor Progression in Melanoma

Malignant melanoma represents one of the most aggressive malignancies but outcome is highly variable with early tumor lesions having an excellent prognosis following resection. We review here the data on identification of genes involved in the progression of melanoma as a result of expression array...

Descripción completa

Detalles Bibliográficos
Autores principales: Rother, Joshua, Jones, Dan
Formato: Texto
Lenguaje:English
Publicado: Bentham Science Publishers Ltd. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709934/
https://www.ncbi.nlm.nih.gov/pubmed/19949544
http://dx.doi.org/10.2174/138920209788488526
_version_ 1782169340999630848
author Rother, Joshua
Jones, Dan
author_facet Rother, Joshua
Jones, Dan
author_sort Rother, Joshua
collection PubMed
description Malignant melanoma represents one of the most aggressive malignancies but outcome is highly variable with early tumor lesions having an excellent prognosis following resection. We review here the data on identification of genes involved in the progression of melanoma as a result of expression array studies, genomic profiling, and genetic models. We focus on the role of tumor suppressors involved in cell cycle function, DNA repair, and genome maintenance. Highlighted are the roles of loss of p16 in promoting neoplasia in cooperation with deregulated MAPK signaling, and the role of loss of the RASSF1A protein in promoting chromosomal instability. The interactions between point mutation in growth signaling molecules and epigenetic changes in genes involved in DNA repair and cell division are discussed.
format Text
id pubmed-2709934
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Bentham Science Publishers Ltd.
record_format MEDLINE/PubMed
spelling pubmed-27099342009-12-01 Molecular Markers of Tumor Progression in Melanoma Rother, Joshua Jones, Dan Curr Genomics Article Malignant melanoma represents one of the most aggressive malignancies but outcome is highly variable with early tumor lesions having an excellent prognosis following resection. We review here the data on identification of genes involved in the progression of melanoma as a result of expression array studies, genomic profiling, and genetic models. We focus on the role of tumor suppressors involved in cell cycle function, DNA repair, and genome maintenance. Highlighted are the roles of loss of p16 in promoting neoplasia in cooperation with deregulated MAPK signaling, and the role of loss of the RASSF1A protein in promoting chromosomal instability. The interactions between point mutation in growth signaling molecules and epigenetic changes in genes involved in DNA repair and cell division are discussed. Bentham Science Publishers Ltd. 2009-06 /pmc/articles/PMC2709934/ /pubmed/19949544 http://dx.doi.org/10.2174/138920209788488526 Text en ©2009 Bentham Science Publishers Ltd. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Rother, Joshua
Jones, Dan
Molecular Markers of Tumor Progression in Melanoma
title Molecular Markers of Tumor Progression in Melanoma
title_full Molecular Markers of Tumor Progression in Melanoma
title_fullStr Molecular Markers of Tumor Progression in Melanoma
title_full_unstemmed Molecular Markers of Tumor Progression in Melanoma
title_short Molecular Markers of Tumor Progression in Melanoma
title_sort molecular markers of tumor progression in melanoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709934/
https://www.ncbi.nlm.nih.gov/pubmed/19949544
http://dx.doi.org/10.2174/138920209788488526
work_keys_str_mv AT rotherjoshua molecularmarkersoftumorprogressioninmelanoma
AT jonesdan molecularmarkersoftumorprogressioninmelanoma